Carfì A, Vetrano DL, Mascia D, Meloni E, Villani ER, Acampora N, Brandi V, Fries BE, Martin L, Bernabei R et al..  2019.  Adults with Down syndrome: a comprehensive approach to manage complexity. Journal of Intellectual Disability Research. 63(6):624-629.

Giovannini S, van der Roest HG, Carfì A, Finne-Soveri H, Garms-Homolova V, Declercq A, Jonsson PV, van Hout H, Vetrano DL, Gravina EManes et al..  2018.  Polypharmacy in home care in Europe: cross-sectional data from the IBenC Study. Drugs & Aging. 35(2):145-152.

Onder G, Vetrano DL, Villani ER, Carfì A, Monaco MRita Lo, Cipriani MCamilla, Gravina EManes, Denkinger M, Pagano F, van der Roest HG et al..  2019.  Deprescribing in Nursing Home Residents on Polypharmacy: Incidence and Associated Factors. Journal of the American Medical Directors Association. 20(9):1116-1120.

Villani ERocco, Vetrano DLiborio, Damiano C, Di Paola A, Ulgiati AMaria, Martin L, Hirdes JP, Fratiglioni L, Bernabei R, Onder G et al..  2020.  Impact of COVID-19-related lockdown on psychosocial, cognitive, and functional well-being in adults with down syndrome. Frontiers in Psychiatry. 11:578686.